Tadolini, M., Lingtsang, R. D., Tiberi, S., Enwerem, M., D'Ambrosio, L., Sadutshang, T. D., . . . Migliori, G. B. (2016). Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine. The European respiratory journal, 48(5), 1527-1529. https://doi.org/10.1183/13993003.01552-2016
Citace podle Chicago (17th ed.)Tadolini, Marina, Rangjung Dolma Lingtsang, Simon Tiberi, Martin Enwerem, Lia D'Ambrosio, Tsetan Dorji Sadutshang, Rosella Centis, a Giovanni Battista Migliori. "Cardiac Safety of Extensively Drug-resistant Tuberculosis Regimens Including Bedaquiline, Delamanid and Clofazimine." The European Respiratory Journal 48, no. 5 (2016): 1527-1529. https://doi.org/10.1183/13993003.01552-2016.
Citace podle MLA (9th ed.)Tadolini, Marina, et al. "Cardiac Safety of Extensively Drug-resistant Tuberculosis Regimens Including Bedaquiline, Delamanid and Clofazimine." The European Respiratory Journal, vol. 48, no. 5, 2016, pp. 1527-1529, https://doi.org/10.1183/13993003.01552-2016.